🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Best Vitelliform Macular Dystrophy

Cell Collection to Study Eye Diseases NCT01432847n/a1 site📍 Bethesda National Eye Institute (NEI) Inherited Retinal Degenerative Disease Registry NCT02435940n/a1 site📍 Columbia Foundation Fighting Blindness Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB) NCT07185256Phase 1, Phase 25 sites📍 Los Angeles📍 Gainsville📍 New York Opus Genetics, Inc · Tests: OPGx-BEST1 Study of BEST1 Vitelliform Macular Dystrophy NCT05809635n/a3 sites📍 New York📍 Paris📍 Tübingen Columbia University · Tests: Natural History Study National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases NCT06491615n/a2 sites📍 Bethesda📍 Bethesda National Eye Institute (NEI)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy